Skip to main content
SpringerLink
Log in

Alemtuzumab-induced thyroid dysfunction examined

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Pariani N, et al. Alemtuzumab-induced thyroid dysfunction exhibits distinctive clinical and immunological features. Journal of Clinical Endocrinology and Metabolism : [15 pages], 6 Jun 2018. Available from: URL: http://dx.doi.org/10.1210/jc.2018-00359

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Alemtuzumab-induced thyroid dysfunction examined. Reactions Weekly 1708, 2 (2018). https://doi.org/10.1007/s40278-018-48095-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-018-48095-9

Search

Navigation